Anastasios Karadimitris
Company: Karadimitris Lab, Imperial College London
Job title: Co-Director - Centre for Haematology
Seminars:
Harnessing Invariant NKT Cells as a Novel Therapeutic Platform for Blood Cancers 2:00 pm
• Evaluating the superior anti-tumour potency of engineered iNKT cells vs T-cells against B-cell lymphoma • Developing iNKT cell immunotherapies targeting novel antigens beyond CD19 for multiple myeloma • Assessing opportunities and challenges in clinically translating engineered iNKT cell therapiesRead more
day: Day One